Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iclaprim vs Linezolid in cSSSI (ASSIST-1)
NCT00299520Phase 3Completed
- Sponsor
- Arpida Ltd
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Iclaprim in Skin and Skin Structure Infection (SSSI), sponsored by Arpida Ltd. Started Jun 2005; status: completed.
02
Drugs
Iclaprim
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00299520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299520.